Concerning the PI3K-AKT signaling pathway, which plays an important role in NSCLC, because it is involved in EGFR receptor tyrosine kinase inhibitor (RTKI) resistance34, most members of the pathway were quantified in the equal loading TMT dataset (Fig. 3a). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.